1-15 of 15
pancreatic cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People

Suping Ling, Karen Brown, Joanne K. Miksza, Lynne Howells, Amy Morrison, Eyad Issa, Thomas Yates, Kamlesh Khunti, Melanie J. Davies, Francesco Zaccardi
Journal: Diabetes Care
Diabetes Care 2020;43(9):2313–2322
https://doi.org/10.2337/dc20-0204
Published: 11 August 2020
View article titled, Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People
Open the PDF for Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People in another window
Journal Articles

Postpancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results From a Nationwide Cancer Registry

Jaelim Cho, Robert Scragg, Maxim S. Petrov
Journal: Diabetes Care
Diabetes Care 2020;43(9):2106–2112
https://doi.org/10.2337/dc20-0207
Published: 02 July 2020
View article titled, Postpancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results From a Nationwide Cancer Registry
Open the PDF for Postpancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results From a Nationwide Cancer Registry in another window
Journal Articles

Response to Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683

Jaelim Cho, Maxim S. Petrov
Journal: Diabetes Care
Diabetes Care 2019;42(12):e191–e192
https://doi.org/10.2337/dci19-0047
Published: 12 November 2019
View article titled, Response to Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683
Open the PDF for Response to Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683 in another window
Journal Articles

Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683

Anne-Claire Devouge, Ninon Foussard, Pauline Poupon, Marie Monlun, Laurence Blanco, Kamel Mohammedi, Vincent Rigalleau
Journal: Diabetes Care
Diabetes Care 2019;42(12):e189–e190
https://doi.org/10.2337/dc19-1504
Published: 12 November 2019
View article titled, Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683
Open the PDF for Comment on Cho et al. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care 2019;42:1675–1683 in another window
Journal Articles

Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors

Minyoung Lee, Jiyu Sun, Minkyung Han, Yongin Cho, Ji-Yeon Lee, Chung Mo Nam, Eun Seok Kang
Journal: Diabetes Care
Diabetes Care 2019;42(11):2057–2064
https://doi.org/10.2337/dc18-2195
Published: 20 August 2019
View article titled, Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors
Open the PDF for Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors in another window
Includes: Supplementary data
Journal Articles

Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer–Associated Diabetes

Wei-Chih Liao, Bo-Shih Huang, Ya-Han Yu, Hsin-Hua Yang, Peng-Ruei Chen, Cheng-Chieh Huang, Hsin-Yi Huang, Ming-Shiang Wu, Lu-Ping Chow
Journal: Diabetes Care
Diabetes Care 2019;42(9):1752–1759
https://doi.org/10.2337/dc19-0217
Published: 01 July 2019
View article titled, Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer–Associated Diabetes
Open the PDF for Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer–Associated Diabetes in another window
Includes: Supplementary data
Journal Articles

Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study

Jaelim Cho, Robert Scragg, Stephen J. Pandol, Mark O. Goodarzi, Maxim S. Petrov
Journal: Diabetes Care
Diabetes Care 2019;42(9):1675–1683
https://doi.org/10.2337/dc19-0145
Published: 21 June 2019
View article titled, Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study
Open the PDF for Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study in another window
Includes: Supplementary data
Journal Articles

Incretin-Based Therapies and the Short-term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies

Mathieu Boniol, Matteo Franchi, Maria Bota, Agnès Leclercq, Joeri Guillaume, Nancy van Damme, Giovanni Corrao, Philippe Autier, Peter Boyle
Journal: Diabetes Care
Diabetes Care 2018;41(2):286–292
https://doi.org/10.2337/dc17-0280
Published: 16 November 2017
View article titled, Incretin-Based Therapies and the Short-term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies
Open the PDF for Incretin-Based Therapies and the Short-term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies in another window
Includes: Supplementary data
Journal Articles

Pancreatic Safety of Sitagliptin in the TECOS Study

John B. Buse, M. Angelyn Bethel, Jennifer B. Green, Susanna R. Stevens, Yuliya Lokhnygina, Pablo Aschner, Carlos Raffo Grado, Tsvetalina Tankova, Julio Wainstein, Robert Josse, John M. Lachin, Samuel S. Engel, Keyur Patel, Eric D. Peterson, Rury R. Holman
Journal: Diabetes Care
Diabetes Care 2017;40(2):164–170
https://doi.org/10.2337/dc15-2780
Published: 14 September 2016
View article titled, Pancreatic Safety of Sitagliptin in the TECOS Study
Open the PDF for Pancreatic Safety of Sitagliptin in the TECOS Study in another window
Includes: Supplementary data
Journal Articles

Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin

Itamar Raz, Deepak L. Bhatt, Boaz Hirshberg, Ofri Mosenzon, Benjamin M. Scirica, Amarachi Umez-Eronini, KyungAh Im, Christina Stahre, Alona Buskila, Nayyar Iqbal, Norton Greenberger, Markus M. Lerch
Journal: Diabetes Care
Diabetes Care 2014;37(9):2435–2441
https://doi.org/10.2337/dc13-2546
Published: 07 August 2014
View article titled, Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin
Open the PDF for Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin in another window
Includes: Supplementary data
Journal Articles

Do GLP-1–Based Therapies Increase Cancer Risk?

Michael A. Nauck, MD, Nele Friedrich, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(Supplement_2):S245–S252
https://doi.org/10.2337/dcS13-2004
Published: 17 July 2013
View article titled, Do GLP-1–Based Therapies Increase Cancer Risk?
Open the PDF for Do GLP-1–Based Therapies Increase Cancer Risk? in another window
Includes: Supplementary data
Journal Articles

Interpreting Adverse Signals in Diabetes Drug Development Programs

Clifford J. Bailey, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(7):2098–2106
https://doi.org/10.2337/dc13-0182
Published: 12 June 2013
View article titled, Interpreting Adverse Signals in Diabetes Drug Development Programs
Open the PDF for Interpreting Adverse Signals in Diabetes Drug Development Programs in another window
Includes: Supplementary data
Journal Articles

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks

Michael A. Nauck, MD,
Journal: Diabetes Care
Diabetes Care 2013;36(7):2126–2132
https://doi.org/10.2337/dc12-2504
Published: 12 June 2013
View article titled, A Critical Analysis of the Clinical Use of Incretin-Based Therapies: <subtitle>The benefits by far outweigh the potential risks</subtitle>
Open the PDF for A Critical Analysis of the Clinical Use of Incretin-Based Therapies: <subtitle>The benefits by far outweigh the potential risks</subtitle> in another window
Includes: Supplementary data
Journal Articles

Proliferation of Colo-357 Pancreatic Carcinoma Cells and Survival of Patients With Pancreatic Carcinoma Are Not Altered by Insulin Glargine

Saskia Erbel, PHD, Christina Reers, PHD, Volker W. Eckstein, PHD, Jörg Kleeff, MD, Markus W. Büchler, MD, Peter P. Nawroth, MD, Robert A. Ritzel, MD
Journal: Diabetes Care
Diabetes Care 2008;31(6):1105–1111
https://doi.org/10.2337/dc07-2015
Published: 01 June 2008
View article titled, Proliferation of Colo-357 Pancreatic Carcinoma Cells and Survival of Patients With Pancreatic Carcinoma Are Not Altered by Insulin Glargine
Open the PDF for Proliferation of Colo-357 Pancreatic Carcinoma Cells and Survival of Patients With Pancreatic Carcinoma Are Not Altered by Insulin Glargine in another window
Journal Articles

IDDM and Pancreatic Carcinoma in Sardinia

Marco Songini, MD
Journal: Diabetes Care
Diabetes Care 1996;19(2):184–185
https://doi.org/10.2337/diacare.19.2.184b
Published: 01 February 1996
View article titled, IDDM and Pancreatic Carcinoma in Sardinia
Open the PDF for IDDM and Pancreatic Carcinoma in Sardinia in another window